Mycobacterial Glycolipid Cord Factor Trehalose 6,6'-dimycolate Causes a Decrease in Serum Cortisol During the Granulomatous Response
Overview
Neurology
Authors
Affiliations
Serum cortisol levels were evaluated in mice following intravenous administration of purified mycobacterial glycolipid trehalose 6,6'-dimycolate (TDM). C57BL/6 mice develop lung granulomas in response to TDM, while A/J mice are deficient in this process. Administration of TDM to C57BL/6 mice led to a rapid reduction in serum cortisol, concurrent with initiation of the granulomatous response and cytokine and chemokine mRNA induction. Cortisol levels were lowest on day 5 after TDM administration, but there was significant production of IL-6, TNF-alpha and IL-1beta messages. Granuloma formation and full immune responsiveness to TDM were only apparent upon a sufficient decrease in levels of systemic cortisol. Treatment of the C57BL/6 mice with hydrocortisone abolished inflammatory responses. Histologically nonresponding A/J mice exhibited higher constitutive serum cortisol and demonstrated different kinetics of cortisol reduction upon administration of TDM. A/J mice demonstrated hyperplastic morphology in the suprarenal gland with a high degree of vacuolization in the medullary region and activation of cells in the zona fasciculata and zona reticularis. The A/J mice were dysregulated with respect to cytokine responses thought to be necessary during granuloma formation. The high constitutive serum cortisol in the A/J mice may therefore contribute to pulmonary immunoresponsiveness and the establishment of an environment counterproductive to the initiation of granulomatous responses. The identification of a mycobacterial glycolipid able to influence serum cortisol levels is unique and is discussed in relation to immunopathology during tuberculosis disease.
Tsolaki A, Varghese P, Kishore U Adv Exp Med Biol. 2021; 1313:179-215.
PMID: 34661896 DOI: 10.1007/978-3-030-67452-6_9.
Does phone messaging improves tuberculosis treatment success? A systematic review and meta-analysis.
Gashu K, Gelaye K, Mekonnen Z, Lester R, Tilahun B BMC Infect Dis. 2020; 20(1):42.
PMID: 31937260 PMC: 6961375. DOI: 10.1186/s12879-020-4765-x.
Hwang S, Kruzel M, Actor J Biochem Cell Biol. 2017; 95(1):148-154.
PMID: 28165282 PMC: 6006514. DOI: 10.1139/bcb-2016-0061.
Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.
Actor J Mediators Inflamm. 2016; 2015:409596.
PMID: 26788020 PMC: 4691619. DOI: 10.1155/2015/409596.
Sakamoto K, Kim M, Rhoades E, Allavena R, Ehrt S, Wainwright H Infect Immun. 2012; 81(3):764-76.
PMID: 23264051 PMC: 3584883. DOI: 10.1128/IAI.00906-12.